Diaceutics PLC Total Liabilities

Latest as of December 2025: GBX9.53 Million GBX ≈ $1.16K USD

Diaceutics PLC total liabilities. Based on the latest financial reports, Diaceutics PLC (DXRX) has total liabilities worth GBX9.53 Million GBX (≈ $1.16K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See DXRX days of operational coverage to measure how many days the company can operate on defensive assets alone.

Total Liabilities of Diaceutics PLC (2015–2025)

Total liabilities of Diaceutics PLC from 2015 to 2025. This chart illustrates how Diaceutics PLC's total liabilities have evolved over time, based on quarterly financial data. Explore Diaceutics PLC long-term investment intensity to see how much of total assets are deployed in long-term investments.

Diaceutics PLC Competitors by Total Liabilities

The table below lists competitors of Diaceutics PLC ranked by their total liabilities.

Company	Country	Total Liabilities
Elevai Labs, Inc. Common Stock NASDAQ:ELAB	USA	$19.83 Million
Globavend Holdings Limited Ordinary Shares NASDAQ:GVH	USA	$1.18 Million
Ragusa Minerals Ltd AU:RAS	Australia	AU$123.10K
Fonix Mobile plc LSE:FNX	UK	GBX71.40 Million
Centaurus Energy Inc V:CTA	Canada	CA$5.59 Million
Fortune Indonesia Tbk JK:FORU	Indonesia	Rp5.72 Billion
Surya Oil & Gas Corp. NASDAQ:SURY	USA	$2.00 Million

Liability Composition Analysis (2015–2025)

This chart breaks down Diaceutics PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see DXRX total asset value.

Liquidity & Leverage Metrics

Diaceutics PLC Total Liabilities Ratios Explained

Diaceutics PLC total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	3.43	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.24	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.19	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Diaceutics PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Diaceutics PLC (2015–2025)

The table below shows the annual total liabilities of Diaceutics PLC from 2015 to 2025.

Year	Total Liabilities	Change
2025-12-31	GBX9.53 Million ≈ $1.16K	+8.73%
2024-12-31	GBX8.76 Million ≈ $1.07K	+57.66%
2023-12-31	GBX5.56 Million ≈ $676.25	-3.20%
2022-12-31	GBX5.74 Million ≈ $698.64	+31.58%
2021-12-31	GBX4.36 Million ≈ $530.97	+33.01%
2020-12-31	GBX3.28 Million ≈ $399.20	+46.54%
2019-12-31	GBX2.24 Million ≈ $272.42	-56.78%
2018-12-31	GBX5.18 Million ≈ $630.37	+43.37%
2017-12-31	GBX3.61 Million ≈ $439.69	+48.82%
2016-12-31	GBX2.43 Million ≈ $295.45	+106.72%
2015-12-31	GBX1.17 Million ≈ $142.92	--

About Diaceutics PLC

LSE:DXRX UK Health Information Services

Market Cap

$2.10 Million

GBX17.27 Billion GBX

Market Cap Rank

#30003 Global

#680 in UK

Share Price

GBX203.50

Change (1 day)

+0.00%

52-Week Range

GBX126.50 - GBX204.50

All Time High

GBX204.50